Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors. 2017

Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.

A series of benzoxazinones 1-28 were synthesized via reaction of anthranilic acid with various substituted benzoyl chlorides in the presence of triethylamine in chloroform. Compounds 1-18 showed a good inhibition of α-chymotrypsin with IC50±SEM values between 6.5 and 341.1μM. Preliminary structure-activity relationships studies indicated that the presence of substituents on benzene ring reduces the inhibitory potential of benzoxazinone. Also the increased inhibitory potential due to fluoro group at phenyl substituent was observed followed by chloro and bromo substituents. Compounds with strong electron donating or withdrawing groups on phenyl substituent, showed a good inhibitory potential at ortho>meta>para position. Kinetics studies showed diverse types of inhibition, except uncompetitive-type inhibition. The Ki values ranged between 4.7 and 341.2μM. Interestingly, most of these compounds were non-cytotoxic to 3T3 cell line at 30μM, except compounds 6, 14 and 15. Competitive inhibitors of chymotrypsin are like to inhibit other α-chymotrypsin-like serine proteases due to structural and functional similarities between them. The inhibitors identified during the current study deserve to be further studied for their therapeutic potential against abnormalities mediated by chymotrypsin or other serine protease.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3
D048588 Benzoxazines OXAZINES with a fused BENZENE ring. Benzoxazine,Benzoxazinoid,Benzoxazinone,Benzoxazinones,Benzoxazinoids
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
February 2003, Bioorganic & medicinal chemistry letters,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
February 2020, European journal of medicinal chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
March 2023, Scientific reports,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
June 2014, European journal of medicinal chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
February 2002, Journal of medicinal chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
January 2014, Current topics in medicinal chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
August 2010, Bioorganic & medicinal chemistry letters,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
October 2021, Future medicinal chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
February 2022, Bioorganic chemistry,
Bishnu P Marasini, and Fazal Rahim, and Shahnaz Perveen, and Aneela Karim, and Khalid Mohammed Khan, and Atta-Ur-Rahman, and M Iqbal Choudhary
January 2018, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!